Which new approaches are pharma companies taking to exploit opportunities offered by big data?
We’ll be answering this question and many more as we discuss big data and related innovative technologies at World Drug Safety Congress Europe. Hear from a plethora of thought leaders who will be sharing real life examples of how to develop big data programmes and social media strategies to enhance the efficiency of drug safety processes. This is your must attend meeting to discover how to implement real, innovative solutions to the challenges surrounding drug safety, pharmacovigilance, benefit risk management, signal detection, global regulations and safety data management.
- Update on the Web-RADR approach in drug safety from Phil Tregunno, Signal Management and Quality Standards Unit Manager, MHRA and David Lewis, Global Head, Pharmacovigilance, Novartis
- Big data informatics in patient safety from Mike Goodman, Systems Area Lead, Safety Informatics, AstraZeneca
- How to use analytical processing and visual communication in pharmacovigilance from Ulrich Vogel, Director, Global Drug Safety, Boehringer Ingelheim
If you are about to begin, or are in the middle of an emerging technology project, you and your staff will find inspiration and ideas from these sessions that you can implement immediately.
We’re making World Drug Safety Congress Europe 2015 even more interactive and engaging with roundtables, panel discussions and plenty of networking time. You will gain valuable tools and techniques to take back and use in your day-to-day role.
This is the event where new safety strategies are explored, new ways of working are implemented and where you can speak directly to pioneers shaping the industry.
Take advantage of our group discount and bring three colleagues for the price of two, exclusively available for pharma and biotech organisations.